---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-305375"
form_type: "8-K"
ticker: "CYH"
cik: "0001108109"
company_name: "COMMUNITY HEALTH SYSTEMS INC"
filed_at: "2025-12-02T23:59:59+00:00"
generated_at: "2026-05-16T15:38:04.305755+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Community Health Systems closes sale of outreach lab assets to Labcorp for $194M cash

## Summary
- Completion of sale of ambulatory outreach laboratory assets to Labcorp for ~$194M cash, before transaction expenses.
- Pro forma adjustments: net operating revenues reduced by $68M (9M 2025) and $92M (FY2024).
- Pro forma net gain on sale of $80M after tax, after ~$23M in transaction expenses and $27M tax.
- Sale does not qualify as discontinued operations; CHS retains inpatient/ED laboratory services.
- Pro forma cash increases from $123M to $275M reflecting $152M net cash proceeds after expenses.

## SEC filing metadata
- accession: 0001193125-25-305375
- form_type: 8-K
- ticker: CYH
- cik: 0001108109
- company_name: COMMUNITY HEALTH SYSTEMS INC
- filed_at: 2025-12-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 9.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1108109/000119312525305375/0001193125-25-305375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1108109/000119312525305375/cyh-20251201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-305375
- JSON: https://secwatch.observer/filing/0001193125-25-305375.json
- Plain text: https://secwatch.observer/filing/0001193125-25-305375.txt

## Source-grounded claims
- claim_id: dca4ebc84ca5b468d1a1089ec31fdee708c8b36d
  claim: COMMUNITY HEALTH SYSTEMS INC completed a disposition involving Laboratory Corporation of America Holdings for approximately $194 million cash, before certain transaction expenses (closed 2025-12-01).
  evidence_excerpt: centers and in-office phlebotomy locations (the transactions contemplated by the Purchase Agreement, the “Transaction”). The purchase price paid to the Company was approximately $194 million cash, before certain transaction expenses. The Purchase Agreement is filed as Exhibit 2.1 (which is incorporated by reference herein) in accordance with the rules of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1108109/000119312525305375/0001193125-25-305375-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.